Logo image of GUT

GABELLI UTILITY TRUST (GUT) Stock Overview

USA - NYSE:GUT - US36240A1016

6.07 USD
+0.04 (+0.66%)
Last: 9/30/2025, 8:04:00 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to GUT. GUT was compared to 0 industry peers in the Unkown industry. The financial health of GUT is average, but there are quite some concerns on its profitability. GUT is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year GUT was profitable.
In the past year GUT had a positive cash flow from operations.
In multiple years GUT reported negative net income over the last 5 years.
In multiple years GUT reported negative operating cash flow during the last 5 years.
GUT Yearly Net Income VS EBIT VS OCF VS FCFGUT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

Industry RankSector Rank
ROA 10.51%
ROE 10.55%
ROIC 1.31%
ROA(3y)-0.19%
ROA(5y)0.73%
ROE(3y)-0.31%
ROE(5y)0.66%
ROIC(3y)1.45%
ROIC(5y)1.28%
GUT Yearly ROA, ROE, ROICGUT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 5 -5 10

1.3 Margins

In the last couple of years the Profit Margin of GUT has declined.
In the last couple of years the Operating Margin of GUT has declined.
In the last couple of years the Gross Margin of GUT has remained more or less at the same level.
Industry RankSector Rank
OM 52.56%
PM (TTM) 333.83%
GM 58.48%
OM growth 3Y3.63%
OM growth 5Y-1.8%
PM growth 3Y-7.91%
PM growth 5Y-7.71%
GM growth 3Y1.75%
GM growth 5Y-1.32%
GUT Yearly Profit, Operating, Gross MarginsGUT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 200 -200 400

More info and screens

5

2. Health

2.1 Basic Checks

GUT has more shares outstanding than it did 1 year ago.
GUT has more shares outstanding than it did 5 years ago.
GUT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
GUT Yearly Shares OutstandingGUT Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
GUT Yearly Total Debt VS Total AssetsGUT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

GUT has an Altman-Z score of 521.36. This indicates that GUT is financially healthy and has little risk of bankruptcy at the moment.
There is no outstanding debt for GUT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 521.36
ROIC/WACCN/A
WACCN/A
GUT Yearly LT Debt VS Equity VS FCFGUT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.3 Liquidity

GUT has a Current Ratio of 0.97. This is a bad value and indicates that GUT is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.97 indicates that GUT may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.97
Quick Ratio 0.97
GUT Yearly Current Assets VS Current LiabilitesGUT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

1

3. Growth

3.1 Past

GUT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 305.56%, which is quite impressive.
The earnings per share for GUT have been decreasing by -17.31% on average. This is quite bad
The Revenue has decreased by -9.22% in the past year.
The Revenue has been decreasing by -1.01% on average over the past years.
EPS 1Y (TTM)305.56%
EPS 3Y-14.19%
EPS 5Y-17.31%
EPS Q2Q%442.86%
Revenue 1Y (TTM)-9.22%
Revenue growth 3Y4.3%
Revenue growth 5Y-1.01%
Sales Q2Q%-11.62%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GUT Yearly Revenue VS EstimatesGUT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 16.41, which indicates a correct valuation of GUT.
GUT's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.76.
Industry RankSector Rank
PE 16.41
Fwd PE N/A
GUT Price Earnings VS Forward Price EarningsGUT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 156.97
EV/EBITDA N/A
GUT Per share dataGUT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 9.88%, GUT is a good candidate for dividend investing.
Compared to an average S&P500 Dividend Yield of 2.41, GUT pays a better dividend.
Industry RankSector Rank
Dividend Yield 9.88%

5.2 History

GUT has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)N/A
Div Incr YearsN/A
Div Non Decr YearsN/A
GUT Yearly Dividends per shareGUT Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

118.17% of the earnings are spent on dividend by GUT. This is not a sustainable payout ratio.
DP118.17%
EPS Next 2YN/A
EPS Next 3YN/A
GUT Yearly Income VS Free CF VS DividendGUT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 0 20M -20M 40M
GUT Dividend Payout.GUT Dividend Payout, showing the Payout Ratio.GUT Dividend Payout.PayoutRetained Earnings

More info and screens

GABELLI UTILITY TRUST

NYSE:GUT (9/30/2025, 8:04:00 PM)

6.07

+0.04 (+0.66%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)03-02 2026-03-02
Inst Owners7.8%
Inst Owner Change-3.7%
Ins Owners1.09%
Ins Owner Change0%
Market Cap538.41M
Analysts0
Price TargetN/A
Short Float %0.66%
Short Ratio2.98
Dividend
Industry RankSector Rank
Dividend Yield 9.88%
Yearly Dividend0.48
Dividend Growth(5Y)N/A
DP118.17%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-Date12-12 2025-12-12 (0.05)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 16.41
Fwd PE N/A
P/S 53.1
P/FCF 156.97
P/OCF 156.97
P/B 1.68
P/tB 1.68
EV/EBITDA N/A
EPS(TTM)0.37
EY6.1%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.04
FCFY0.64%
OCF(TTM)0.04
OCFY0.64%
SpS0.11
BVpS3.62
TBVpS3.62
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 10.51%
ROE 10.55%
ROCE 1.66%
ROIC 1.31%
ROICexc 1.31%
ROICexgc 1.31%
OM 52.56%
PM (TTM) 333.83%
GM 58.48%
FCFM 33.83%
ROA(3y)-0.19%
ROA(5y)0.73%
ROE(3y)-0.31%
ROE(5y)0.66%
ROIC(3y)1.45%
ROIC(5y)1.28%
ROICexc(3y)1.45%
ROICexc(5y)1.28%
ROICexgc(3y)1.45%
ROICexgc(5y)1.28%
ROCE(3y)1.83%
ROCE(5y)1.62%
ROICexcg growth 3Y14.16%
ROICexcg growth 5Y0.23%
ROICexc growth 3Y14.16%
ROICexc growth 5Y0.23%
OM growth 3Y3.63%
OM growth 5Y-1.8%
PM growth 3Y-7.91%
PM growth 5Y-7.71%
GM growth 3Y1.75%
GM growth 5Y-1.32%
F-Score4
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion N/A
Profit Quality 10.13%
Current Ratio 0.97
Quick Ratio 0.97
Altman-Z 521.36
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)305.56%
EPS 3Y-14.19%
EPS 5Y-17.31%
EPS Q2Q%442.86%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-9.22%
Revenue growth 3Y4.3%
Revenue growth 5Y-1.01%
Sales Q2Q%-11.62%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-20.33%
EBIT growth 3Y8.09%
EBIT growth 5Y-2.8%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-90.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-90.97%
OCF growth 3YN/A
OCF growth 5YN/A